In Brief: Boehringer Mannheim
This article was originally published in The Gray Sheet
Executive Summary
Boehringer Mannheim: CoaguChek system for prothombin time testing to monitor warfarin anticoagulation therapy gains CLIA-waived status from the Centers for Disease Control and Prevention, permitting patient home-use of the system. Exemption from requirements of the Clinical Laboratory Improvement Amendments of 1988 also translates into cost savings for professional users, Boehringer claims...